Mode
Home
Conditions Medications Drug Pipeline Weekly Digests
Text Size
Log in / Sign up
Home › Medications › divalproex sodium

divalproex sodium

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Depakote (divalproex sodium) for Manic Episodes Associated with Bipolar Disorder
Neurology FDA Approval
FDA Approves Depakote (divalproex sodium) for Manic Episodes Associated with Bipolar Disorder FDA approves Depakote for treating manic episodes in bipolar disorder.
The FDA approved Depakote (divalproex sodium) for the treatment of manic episodes associated with bipolar disorder. The approval was based o…
FDA approves Depakote for treating manic episodes in hospitalized adults with bipolar disorder, offering doctors a new option for managing a…
FDA Apr 2, 2026
FDA Approves Depakote ER (divalproex sodium) for Acute Manic or Mixed Episodes in Bipolar Disorder
Neurology FDA Approval
FDA Approves Depakote ER (divalproex sodium) for Acute Manic or Mixed Episodes in Bipolar Disorder FDA approves a new once-daily pill for treating manic episodes in bipolar disorder.
The FDA has approved Depakote ER, an extended-release valproate, for the acute treatment of manic or mixed episodes associated with bipolar …
FDA approves a new once-daily pill for short-term treatment of severe manic episodes in adults with bipolar I disorder.
FDA Apr 2, 2026